ClinicalTrials.Veeva

Menu

Breath Analysis of Patients Diagnosed With COVID-19 Using Infrared Spectroscopy (BREATH)

McMaster University logo

McMaster University

Status

Unknown

Conditions

SARS-CoV-2 Infection
Covid19

Study type

Observational

Funder types

Other
Industry

Identifiers

Details and patient eligibility

About

To analyze Volatile Organic Compounds (VOCs) in the breath of patients with SARS-CoV-2 and controls in SARS-CoV-2 breath specimens.

Full description

The study is a prospective cohort study, which enrol patients presenting to hospital and are tested for SARS-CoV-2. There will be two cohorts, COVID-19 positive and COVID-19 negative, who will have exhaled breath collection and analysis by infrared spectroscopy to characterize the composition of VOCs and identify differences in VOC profiles between the two groups.

Enrollment

200 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria for Covid-19 positive patients:

  • Clinically tested for SARS-CoV-2 (as completed by standard laboratory testing e.g. RT-PCR) with a positive result
  • Clinical features in keeping with COVID-19 illness.

Inclusion criteria for Covid-19 negative patients:

  • Negative RT-PCR COVID-19 test
  • Without any clinical features to suggest COVID-19 illness.
  • No known or current features of respiratory infection, COPD, asthma, interstitial lung disease, other respiratory inflammatory conditions or lung cancer.
  • Able to provide a breath sample (as based on clinical judgement).

Exclusion Criteria for Covid-19 positive and negative patients:

  • Unable to provide a breath sample

Trial design

200 participants in 2 patient groups

SARS-CoV-2 Positive
Description:
Clinically tested for SARS-CoV-2 (as completed by standard laboratory testing e.g. RT-PCR) and with a positive result and clinical features in keeping with COVID-19 illness. The investigators aim to collect breath samples within 7 days of symptom onset in 50% of Covid positive patients, with the remaining patients breath samples collected after 7 days of symptoms onset.
SARS-CoV-2 Negative
Description:
Patients with a negative RT-PCR COVID-19 test and without any clinical features to suggest COVID-19 illness.

Trial contacts and locations

1

Loading...

Central trial contact

Gail Gauvreau, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems